Prelude Capital Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-677
| Closed | -$45.7K | – | 1219 |
|
|
2023
Q2 | $45.7K | Buy |
+677
| New | +$280K | ﹤0.01% | 978 |
|
|
2021
Q4 | – | Sell |
-596
| Closed | -$152K | – | 2108 |
|
|
2021
Q3 | $152K | Buy |
596
+144
| +32% | +$51K | 0.01% | 1430 |
|
|
2021
Q2 | $301K | Buy |
+452
| New | +$260K | 0.02% | 1192 |
|
|
2020
Q4 | – | Sell |
-98
| Closed | -$100K | – | 1573 |
|
|
2020
Q3 | $100K | Sell |
98
-78
| -44% | -$83.9K | 0.01% | 906 |
|
|
2020
Q2 | $178K | Buy |
+176
| New | +$163K | 0.03% | 772 |
|
|
2020
Q1 | – | Sell |
-27
| Closed | -$29K | – | 1675 |
|
|
2019
Q4 | $29K | Buy |
27
+25
| +1,250% | +$25.5K | ﹤0.01% | 1505 |
|
|
2019
Q3 | $2K | Buy |
+2
| New | +$2.2K | ﹤0.01% | 1617 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1853 |
|
|
2019
Q1 | – | Sell |
-167
| Closed | -$226K | – | 1923 |
|
|
2018
Q4 | $193K | Buy |
+167
| New | +$188K | 0.02% | 742 |
|
|
2018
Q3 | – | Sell |
-42
| Closed | -$65K | – | 1845 |
|
|
2018
Q2 | $65K | Buy |
+42
| New | +$54.8K | 0.01% | 1060 |
|
|
2018
Q1 | – | Sell |
-69
| Closed | -$82K | – | 1593 |
|
|
2017
Q4 | $82K | Sell |
69
-20
| -22% | -$25.1K | 0.01% | 835 |
|
|
2017
Q3 | $120K | Buy |
+89
| New | +$93.8K | 0.01% | 826 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1625 |
|
|
2016
Q3 | – | Sell |
-184
| Closed | -$86.7K | – | 1661 |
|
|
2016
Q2 | $75K | Buy |
184
+60
| +48% | +$27.5K | 0.01% | 859 |
|
|
2016
Q1 | $66K | Buy |
124
+24
| +24% | +$12K | 0.01% | 890 |
|
|
2015
Q4 | $76K | Buy |
+100
| New | +$66.4K | 0.01% | 912 |
|
Other funds holding KYNB
AC
